MSB 2.51% 97.0¢ mesoblast limited

Ann: MSB Wins Fierce Biotech Innovation Award for Remestemcel-L, page-201

  1. 583 Posts.
    lightbulb Created with Sketch. 4970
    Hi 'Eyes'

    Yes, Lonza is our our key manufacturing partner but ...
    MSB has so many pipelines and such a huge IP catalogue, I would find it staggering that we would even try to 'go it alone' in EVERY indication.
    Yes, in a number of areas we will and can comfortably go it alone. We have 'geared up' to do this.
    MSB is about to become the 'gold standard' in multiple indications. Seriously, this will require several partnerships IMO.
    This is all good. I just can't get my head around just how good. Enormous. This is a whole new 'ball game' - and its game on !!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.